drugset / Trial / NCT02187523
Relative Oral Bioavailability of Telmisartan / Hydrochlorothiazide (HCTZ) Fixed Dose Combination (FDC) Compared With Its Monocomponents in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
A study to demonstrate the bioequivalence of telmisartan and HCTZ administered as fixed dose combination in comparison to the single unit formulations
Timeline
- Start
- 1999-10
- Primary completion
- 1999-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydrochlorothiazide | Unknown | — | Oral |
| Subject | Telmisartan | Other / unclassified | — | Oral |
Indications
No indication recorded.